Shares of several companies including BPCL, HDFC Bank, HUL, Polycab India, Persistent Systems, Aurobindo Pharma, among others ...

Aurobindo Pharma Ltd share price was down by -1.25% from the previous closing price of ₹1,202.05. Who are peers of Aurobindo Pharma Ltd? The peers of Aurobindo Pharma Ltd are Sun Pharmaceuticals ...

The firm expects mid-single-digit price erosion in generic drugs and heightened competition for key medications, potentially ...

AUROBINDO PHARMA LTD.has informed BSE that the meeting of the Board ... head of the Company where-in PAN of the Company was mentioned. Intimation of loss of Share Certificate. Intimation of closure of ...

Company has Deloitte Haskins & Sells as its auditors. As on 31-12-2024, the company has a total of 58.08 Crore shares outstanding.Aurobindo Pharma Share Price Today is Rs. 1244.80. On previous day, ...

Glaxosmithkline Pharmaceuticals Ltd share price was down by 0.00% from the ... Zydus Lifesciences Ltd, Lupin Ltd, Aurobindo Pharma Ltd, Alkem Laboratories Ltd, Who is/are the promoter/promoters ...

Today’s stock recommendations feature a mix of picks from the pharmaceutical, insurance, and chemicals sectors.

CLSA analysts upgraded Aurobindo Pharma (NSE:ARBN) (ARBP:IN) stock rating from Hold to Outperform, despite reducing the price target to INR1,400 from INR1,540. The revision reflects a modified ...

28 May, 2015 20 Jul, 2015 1:1 For every 1 share held; Holder will receive 1 bonus shares. 22 Feb, 2000 07 Mar, 2000 1:1 For every 1 share held; Holder will receive 1 bonus shares. 08 Oct ...

Check OneSource Specialty Pharma Stock Price live NSE/BSE on financialexpress.com. Get OneSource Specialty Pharma today's stock price, 52-week high, 52-week low, OneSource Specialty Pharma quarterly ...

The top holdings of the fund include Sun Pharmaceutical Industries, Aurobindo Pharma, Cipla & Dr Reddys Laboratories. The major sectors where the fund is invested are Biotechnology & Drugs ...

Shares of Ascentage Pharma Group International pared earlier losses to rise 0.75% in the Chinese biopharmaceutical company’s ...